AI-CVD vs Viz RV/LV

Viz RV/LV offers a more comprehensive and active approach to usability by integrating AI-powered alerts, a high-fidelity mobile DICOM image viewer, and a HIPAA-compliant communication platform to streamline acute care workflows and accelerate treatment decisions. While AI-CVD emphasizes minimal workflow disruption by leveraging existing CT scans for opportunistic screening, Viz RV/LV's integrated solution for rapid response and care team coordination provides a more robust set of usability enhancements for its specific use case.

AI-CVD provides broader clinical value through opportunistic screening for a wide array of cardiovascular and multisystem diseases, including coronary heart disease, heart failure, atrial fibrillation, stroke, osteoporosis, liver steatosis, and diabetes, by leveraging existing CT scans. It has demonstrated the ability to predict future cardiovascular and metabolic events, outperforming conventional clinical scores. This comprehensive, multi-system approach for early detection across millions of scans offers significant potential for long-term, widespread clinical impact in preventive care.

Both tools lack publicly available pricing information. However, Viz.ai explicitly states that it was the 'first company to be awarded CMS reimbursement for AI' and highlights that organizations using its platform have seen measurable workflow gains, better outcomes, increased productivity, and enhanced hospital economics. This suggests a more established and transparent value proposition in terms of financial viability and return on investment for healthcare systems.

Viz RV/LV demonstrates stronger enterprise readiness with explicit confirmation of HIPAA compliance and BAA availability in its specifications. Its 'Viz One: Enterprise Platform' is designed for interoperability, scalability, and security, integrating seamlessly with existing PACS, EHR, and cloud environments, and is supported by Microsoft Cloud for Healthcare. Furthermore, Viz.ai has received SOC 2 certification and is deployed in 2,000 hospitals, indicating a robust and secure enterprise-grade solution.

While AI-CVD's opportunistic screening across multiple systems is innovative, Viz RV/LV's recent launch of Viz Agent Studio represents a significant leap in empowering healthcare organizations. This new capability allows health systems to build and scale their own custom AI care pathways using natural language, operationalizing clinical guidelines across the enterprise and enabling broader, customizable AI application within clinical workflows. This offers a higher degree of flexibility and adaptability in leveraging AI for diverse clinical scenarios.

Viz RV/LV clearly outlines a comprehensive support structure, including 24/7 urgent support with a guaranteed 15-minute response time, dedicated clinical specialists, implementation experts, and a customer success team. It also offers in-app and email support with a next business day response. AI-CVD provides contact information and a knowledge center, but lacks the detailed, round-the-clock, and multi-channel support commitment demonstrated by Viz RV/LV.